BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36473142)

  • 1. Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer Treatment.
    Rocque GB; Andrews C; Lawhon VM; Frazier R; Ingram SA; Smith ML; Wagner LI; Zubkoff L; Tung N; Wallner LP; Wolff AC
    JCO Oncol Pract; 2023 Feb; 19(2):e263-e273. PubMed ID: 36473142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials.
    Rocque GB; Andrews C; Lawhon VM; Ingram SA; Frazier RM; Smith ML; Wagner LI; Zubkoff L; Wallner LP; Wolff AC
    Oncologist; 2022 Dec; 27(12):1067-1073. PubMed ID: 36215065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' Hierarchy of Tumor Biomarkers for Optimizing Chemotherapy in Breast Cancer Care.
    Thannickal HH; Eltoum N; Henderson NL; Wallner LP; Wagner LI; Wolff AC; Rocque GB
    Oncologist; 2024 Jan; 29(1):e38-e46. PubMed ID: 37405703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists.
    Wong AR; Sun V; George K; Liu J; Padam S; Chen BA; George T; Amini A; Li D; Sedrak MS
    JCO Oncol Pract; 2020 Sep; 16(9):e849-e858. PubMed ID: 32240068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer.
    Hull O; Niranjan SJ; Wallace AS; Williams BR; Turkman YE; Ingram SA; Williams CP; Smith T; Knight SJ; Bhatia S; Rocque GB
    Breast Cancer Res Treat; 2020 Nov; 184(1):115-121. PubMed ID: 32737711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
    Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
    Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative study of barriers and facilitators to adolescents and young adults' participation in cancer clinical trials: Oncologist and patient perspectives.
    Abrahão R; Alvarez EM; Waters AR; Romero CC; Gosdin MM; Naz H; Pollock BH; Kirchhoff AC; Keegan THM
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29479. PubMed ID: 34913583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates.
    Andrews C; Childers TC; Wiseman KD; Lawhon V; Ingram S; Smith ML; Wolff AC; Wagner L; Rocque GB
    BMC Cancer; 2022 Feb; 22(1):141. PubMed ID: 35120494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to clinical trial enrollment of older adults with cancer: A qualitative study of the perceptions of community and academic oncologists.
    Sedrak MS; Mohile SG; Sun V; Sun CL; Chen BT; Li D; Wong AR; George K; Padam S; Liu J; Katheria V; Dale W
    J Geriatr Oncol; 2020 Mar; 11(2):327-334. PubMed ID: 31375399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Clinical trials are space travel": Factors of psychological response to recurrence among oncologists enrolling patients in treatment optimization trials.
    Henderson NL; Andrews C; Ingram SA; Zubkoff L; Tung N; Wagner LI; Wallner LP; Wolff A; Rocque GB
    Cancer Med; 2023 Dec; 12(23):21490-21501. PubMed ID: 37947134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives.
    Siembida EJ; Loomans-Kropp HA; Tami-Maury I; Freyer DR; Sung L; Crosswell HE; Pollock BH; Roth ME
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
    Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
    Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes and practices about fertility preservation discussions among young adults with cancer treated at a comprehensive cancer center: patient and oncologist perspectives.
    Salsman JM; Yanez B; Snyder MA; Avina AR; Clayman ML; Smith KN; Purnell K; Victorson D
    Support Care Cancer; 2021 Oct; 29(10):5945-5955. PubMed ID: 33763727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical oncologist perspectives on palliative care reveal physician-centered barriers to early integration.
    Kruser TJ; Kruser JM; Gross JP; Moran M; Kaiser K; Szmuilowicz E; Kircher SM
    Ann Palliat Med; 2020 Sep; 9(5):2800-2808. PubMed ID: 32787372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to participation in clinical trials: a physician survey.
    Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
    Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic communication about lung cancer in the precision oncology era: A multiple-perspective qualitative study.
    Petrillo LA; Shimer SE; Zhou AZ; Sommer RK; Feldman JE; Hsu KE; Greer JA; Traeger LN; Temel JS
    Cancer; 2022 Aug; 128(16):3120-3128. PubMed ID: 35731234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers.
    Knelson LP; Cukras AR; Savoie J; Agarwal A; Guo H; Hu J; Fell G; Lederman R; Hughes ME; Winer EP; Lin NU; Tolaney SM
    Clin Breast Cancer; 2020 Oct; 20(5):395-401.e3. PubMed ID: 32605813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators for clinical trial participation among diverse Asian patients with breast cancer: a qualitative study.
    Lee GE; Ow M; Lie D; Dent R
    BMC Womens Health; 2016 Jul; 16():43. PubMed ID: 27449505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.